Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;51(10):2143-2171.
doi: 10.1007/s10439-023-03321-y. Epub 2023 Jul 19.

New Solutions for Old Problems: How Reproductive Tissue Engineering Has Been Revolutionizing Reproductive Medicine

Affiliations
Review

New Solutions for Old Problems: How Reproductive Tissue Engineering Has Been Revolutionizing Reproductive Medicine

Ellen C R Leonel et al. Ann Biomed Eng. 2023 Oct.

Abstract

Acquired disorders and congenital defects of the male and female reproductive systems can have profound impacts on patients, causing sexual and endocrine dysfunction and infertility, as well as psychosocial consequences that affect their self-esteem, identity, sexuality, and relationships. Reproductive tissue engineering (REPROTEN) is a promising approach to restore fertility and improve the quality of life of patients with reproductive disorders by developing, replacing, or regenerating cells, tissues, and organs from the reproductive and urinary systems. In this review, we explore the latest advancements in REPROTEN techniques and their applications for addressing degenerative conditions in male and female reproductive organs. We discuss current research and clinical outcomes and highlight the potential of 3D constructs utilizing biomaterials such as scaffolds, cells, and biologically active molecules. Our review offers a comprehensive guide for researchers and clinicians, providing insights into how to reestablish reproductive tissue structure and function using innovative surgical approaches and biomaterials. We highlight the benefits of REPROTEN for patients, including preservation of fertility and hormonal production, reconstruction of uterine and cervical structures, and restoration of sexual and urinary functions. Despite significant progress, REPROTEN still faces ethical and technical challenges that need to be addressed. Our review underscores the importance of continued research in this field to advance the development of effective and safe REPROTEN approaches for patients with reproductive disorders.

Keywords: Artificial organs; Engineered tissue; Fertility restoration; Regenerative medicine; Reproductive organs; Stem cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Al Abbar, A., S. C. Ngai, N. Nograles, S. Y. Alhaji, and S. Abdullah. Induced pluripotent stem cells: reprogramming platforms and applications in cell replacement therapy. Biores Open Access. 9:121–136, 2020. - PubMed - PMC - DOI
    1. Abu Elhija, M., E. Lunenfeld, S. Schlatt, and M. Huleihel. Differentiation of murine male germ cells to spermatozoa in a soft agar culture system. Asian J. Androl. 14:285–293, 2012. - PubMed - DOI
    1. Adamowicz, J., K. Juszczak, A. Bajek, J. Tworkiewicz, M. Nowacki, A. Marszalek, P. J. Thor, P. Chlosta, and T. Drewa. Morphological and urodynamic evaluation of urinary bladder wall regeneration: muscles guarantee contraction but not proper function—a rat model research study. Transplant Proc. 44:1429–1434, 2012. - PubMed - DOI
    1. Afshar, L., H.-R. Aghayan, J. Sadighi, B. Arjmand, S.-M. Hashemi, M. Basiri, R. O. Samani, M. K. Ashtiani, S.-A. Azin, and E. Hajizadeh-Saffar. Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran. Stem Cell Res. Ther. 11:1–5, 2020. - DOI
    1. Akbarzadeh, A., M. Kianmanesh, K. Fendereski, M. Ebadi, S. S. Daryabari, A. Masoomi, F. Ghazisaeedi, R. S. H. Beigi, R. Sheikh, and A.-M. Kajbafzadeh. Decellularised whole ovine testis as a potential bio-scaffold for tissue engineering. Reprod. Fertil. Dev. 31:1665–1673, 2019. - PubMed - DOI

Substances

LinkOut - more resources